Trial intelligence / Profile preview

SVF (Autologous ADSC) for Chronic Kidney Disease

NCT03939741Phase 2Unknown

Sponsor
Bangladesh Laser & Cell Surgery Institute & Hospital
Start
Apr 2019
Primary completion
Mar 2024
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in chronic kidney disease (CKD), sponsored by Bangladesh Laser & Cell Surgery Institute & Hospital. Status: unknown.

02

Drugs

autologous adipose-derived mesenchymal stromal cells
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT03939741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03939741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call